NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Amos Grünebaum: The Present and the Future of Baby Making
Amos Grünebaum/LinkedIn
Sep 10, 2026, 15:37

Amos Grünebaum: The Present and the Future of Baby Making

Amos Grünebaum, Professor of Obstetrics and Gynecology at Donald and Barbara Zucker School of Medicine, shared on LinkedIn:

“A colleague is speaking on ‘The Future of Baby Making.’

I would like to hear the talk called ‘The Present.’

In 2022, US clinics ran 435,426 ART cycles and produced 98,289 infants – 2.6% of all US births. That 2.6% gets the conferences, the capital, and the word ‘future.’

The other 97.4% got this: first-trimester prenatal care down to 76.1%, no prenatal care up 5%, preterm birth stuck at 10.4% for twenty years.

Look at which parts of reproduction get called the future. Embryo selection. The add-on menu. Surrogacy.

What they share is not evidence. It is a price tag, paid directly, billed per cycle and per journey.

And often the evidence is thin. PGT-A, endometrial receptivity testing, most add-ons – none have raised live birth per intended patient, which is the outcome women think they are buying.

Meanwhile, IVF is largely a workaround for what we failed to prevent upstream: deferred childbearing, untreated infection, obesity, metabolic disease in men.

Nobody markets prevention. There is nothing to invoice.

Ask what the future holds for the 97.4%.

If the room goes quiet, that is the talk worth giving.”

Read further.

Other articles featuring Amos Grünebaum on Fertility News.

Amos Grünebaum ART Assisted Reproductive Technology embryo selection Endometrial Receptivity Testing Fertility Fertility Add-Ons Fertility News in vitro fertilization IVF live birth maternal health OBGYN ObGyn Intelligence PGT-A prenatal care preterm birth Preventive Care reproductive health Reproductive Medicine reproductive technology Surrogacy Women’s Health
NewsFeed